<DOC>
	<DOCNO>NCT01119573</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor identify learn biomarkers related cancer . PURPOSE : This research study study biomarkers tissue sample patient stage I stage III endometrial cancer .</brief_summary>
	<brief_title>Biomarkers Tissue Samples From Patients With Stage I Stage III Endometrial Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To identify microRNA expression pattern associate lymph node metastasis sample patient endometrial cancer . OUTLINE : Banked tumor tissue specimens analyze microRNA expression profile microarray analysis reverse transcriptase-PCR assay .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm endometrioid endometrial cancer Stage IA , IB , IC , IIIC disease Any grade Enrolled evaluate GOG0210 Molecular Staging Study Endometrial Cancer Consented allow specimen clinical data collect stored future research Underwent complete surgical staging , include follow : Hysterectomy Bilateral oophorectomy Washings well pelvic lymphadenectomy ( sample four leave four right pelvic lymph node ) Paraaortic lymphadenectomy ( sample one leave one right paraaortic lymph node ) Sufficient highquality freeze primary tumor test ≥ 75 % tumor cellularity ≤ 10 % necrosis PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>stage I endometrial carcinoma</keyword>
	<keyword>stage III endometrial carcinoma</keyword>
</DOC>